DH

In the past six months, Definitive Healthcare Corp. (DH) stock has experienced a significant decline. The company reported its first-quarter 2026 financial results with a revenue decrease and a sharp net loss due to a non-cash goodwill impairment charge. Management cited continued weakness in the life sciences vertical, past sales execution challenges, macroeconomic pressure, and elevated churn as contributing factors. The company initiated a 2026 restructuring plan, reducing headcount. Analysts have lowered price targets for Definitive Healthcare.